Indomethacin Germinal Matrix Hemorrhage/Intraventricular Hemorrhage (GMH/IVH) Prevention Trial - Related Studies

Indomethacin Germinal Matrix Hemorrhage/Intraventricular Hemorrhage (GMH/IVH) Prevention Trial

This study is ongoing, but not recruiting participants.

Study NCT00033917. Last updated on December 5, 2007. Information provided by National Institute of Neurological Disorders and Stroke (NINDS)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Intraventricular Hemorrhage (IVH)
		Bleeding in the Brain
		Prematurity
		Very Low Birth Weight Infants

2	Additional conditions recognized in this trial
		Birth Weight
		Hemorrhage

3	More general conditions related to this trial
		Body Weight
		Pathologic Processes
		Signs and Symptoms

4	Interventions listed in this trial
		indomethacin
		placebo

5	More general drug interventions related to this trial
		Analgesics
		Analgesics, Non-Narcotic
		Anti-Inflammatory Agents
		Anti-Inflammatory Agents, Non-Steroidal
		Antirheumatic Agents
		Cardiovascular Agents
		Central Nervous System Agents
		Cyclooxygenase Inhibitors
		Enzyme Inhibitors
		Gout Suppressants
		Molecular Mechanisms of Pharmacological Action
		Peripheral Nervous System Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Reproductive Control Agents
		Sensory System Agents
		Therapeutic Uses
		Tocolytic Agents

6	Sponsors listed in this trial
		National Institute of Neurological Disorders and Stroke (NINDS)